Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,889 INR | +0.12% | +1.33% | +16.27% |
Sales 2024 * | 35.01B 420M | Sales 2025 * | 40.58B 486M | Capitalization | 293B 3.51B |
---|---|---|---|---|---|
Net income 2024 * | 5.64B 67.6M | Net income 2025 * | 7.06B 84.65M | EV / Sales 2024 * | 8.41 x |
Net Debt 2024 * | 1.32B 15.8M | Net cash position 2025 * | 4.41B 52.9M | EV / Sales 2025 * | 7.11 x |
P/E ratio 2024 * |
49
x | P/E ratio 2025 * |
39.2
x | Employees | 5,095 |
Yield 2024 * |
0.59% | Yield 2025 * |
0.76% | Free-Float | 45.82% |
Latest transcript on J. B. Chemicals & Pharmaceuticals Limited
1 day | +0.12% | ||
1 week | +1.33% | ||
Current month | -0.81% | ||
1 month | +12.15% | ||
3 months | +11.90% | ||
6 months | +35.00% | ||
Current year | +16.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-10-04 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-30 | |
Akshay Tanna
BRD | Director/Board Member | 40 | Nov. 06 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 21-02-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.67% | - | |
0.00% | 117 M€ | +2.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1,889 | +0.12% | 3,376 |
24-05-02 | 1,886 | -0.93% | 1,383 |
24-04-30 | 1,904 | -0.12% | 2,161 |
24-04-29 | 1,906 | +2.27% | 2,921 |
24-04-26 | 1,864 | +0.48% | 973 |
Delayed Quote Bombay S.E., May 03, 2024 at 06:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.27% | 3.51B | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- JBCHEPHARM Stock